Wespac Advisors So Cal, LLC Pfizer Inc Transaction History

Wespac Advisors So Cal, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 30, 2019	SELL	$36.98 - $41.52 $61,423 - $68,964	-1,661 Closed	0 $0
Q4 2018 Feb 07, 2019	BUY	$38.47 - $43.86 $5,770 - $6,579	150 Added 9.93%	1,661 $68,000
Q3 2018 Oct 22, 2018	BUY	$34.47 - $41.81 $52,084 - $63,174	1,511 New	1,511 $66,000
Q2 2018 Jul 13, 2018	SELL	$32.98 - $35.16 $24,174 - $25,772	-733 Closed	0 $0
Q1 2018 Apr 16, 2018	BUY	$31.91 - $37.02 $18,220 - $21,138	571 Added 352.47%	733 $26,000
Q4 2017 Feb 13, 2018	BUY	$33.26 - $35.29 $5,388 - $5,716	162	162 $5,000

3,222

3.71B

73.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $161B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Wespac Advisors So Cal, LLC, based on Form 13F filings with the SEC.

Stay updated on Wespac Advisors So Cal, LLC with notifications on news.